As of March 7th 2013, the European Commission finalised and published the long awaited new Good Distribution Practice (GDP) guidelines. The European Medicines Agency (EMEA) has since stepped up its commitment to monitoring and controlling who is complying and implementing the new requirements by increasing its inspection manpower.
Read more at: PRNewswire